Abbott Laboratories is a large health care and pharmaceutical company. According to its filings, it lobbied Congress mainly on health issues, especially access and regulatory rules for infant formula and preterm infant formula, including work related to H.R.2300. Its filings show four reports totaling about $200,000 and it used W Strategies, LLC for lobbying.
Show the dominant industry call, how mixed the client looks, and the allocation across the top labeled sectors.
Annual totals based on disclosed filing amounts.
Issue rankings are based on disclosed activity mentions, with filing amounts apportioned evenly across issues within the same filing.
The lobbying registrants handling this client, ranked by disclosed filing amounts.
Lobbyists are ranked by appearances and an equal share of each filing's reported amount.
DARREN WILLCOX
The latest disclosures for this client.
W STRATEGIES, LLC
Q1W STRATEGIES, LLC
Q4The entities named in disclosed activities are the clearest available signal for where the client is aiming attention.
W STRATEGIES, LLC
W STRATEGIES, LLC
Q3W STRATEGIES, LLC
Q2W STRATEGIES, LLC
Q1